RT Journal Article
SR Electronic
T1 Verapamil: a cause of sudden death in a patient with hypertrophic cardiomyopathy.
JF British Heart Journal
JO Heart
FD BMJ Publishing Group Ltd and British Cardiovascular Society
SP 352
OP 354
DO 10.1136/hrt.51.3.352
VO 51
IS 3
A1 Perrot, B
A1 Danchin, N
A1 Terrier de la Chaise, A
YR 1984
UL http://heart.bmj.com/content/51/3/352.abstract
AB Sudden death was recorded by continuous ambulatory electrocardiographic (Holter) monitoring in a 62 year old man with hypertrophic cardiomyopathy and atrial fibrillation, who had been treated for four days with verapamil 360 mg orally. Analysis of the tape showed a third degree atrioventricular block followed by complete asystole. The sudden death could be related to treatment with verapamil.